MNM Bioscience

Neoantigen cancer immunotherapy · Solid tumors

Overview

AI-driven neoantigen prediction for personalized cancer immunotherapies and vaccines; Poznań roots with US expansion.

What they do

MNM Bioscience was a biotechnology startup applying artificial intelligence to neoantigen discovery for personalized cancer immunotherapy. Founded in 2018 (reportedly by Paweł Zawadzki and Katarzyna Zawadzka) with roots in Poznań, Poland and an incorporated U.S. entity (MNM Bioscience Inc.), the company built computational platforms to interpret tumour genetic data and predict patient-specific neoantigens, the mutated targets used to design personalized cancer vaccines and other immunotherapies for solid tumours.

Lead program & status

The core asset was an AI-driven neoantigen-prediction and patient-stratification platform intended to identify which patients are most likely to respond to immunotherapy and to nominate vaccine targets and drug-discovery leads. In 2022 the company secured roughly $800,000 in Eureka Eurostars funding for an AI-based cancer patient-stratification tool, and reported total funding in the low single-digit millions. Public records (e.g., Crunchbase) indicate the company is no longer active and reportedly closed, so its programs did not reach a publicly reported clinical-stage milestone. Readers should treat status details as of the most recent available records.

Why it matters

MNM reflected the broader wave of AI-led neoantigen platforms feeding personalized cancer vaccines, a field where computational target selection is now central to mRNA and peptide vaccine programs worldwide, even as individual startups face steep commercialization and funding hurdles.

FAQ

What was MNM Bioscience's focus?

AI-driven neoantigen prediction to power personalized cancer immunotherapies and vaccines, plus patient stratification for immunotherapy response.

Where was MNM Bioscience based?

It had roots in Poznań, Poland, with a U.S.-incorporated entity (MNM Bioscience Inc.) supporting its expansion.

Is MNM Bioscience still operating?

Public records suggest the company is no longer active and has reportedly closed; status should be verified against the latest sources.

Company website / source ↗ Open the interactive map →